These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26474010)

  • 21. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
    Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
    Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
    Weisler R; Joyce M; McGill L; Lazarus A; Szamosi J; Eriksson H;
    CNS Spectr; 2009 Jun; 14(6):299-313. PubMed ID: 19668121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
    Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
    Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
    Kanba S; Murasaki M; Koyama T; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
    BMC Psychiatry; 2019 Jun; 19(1):198. PubMed ID: 31242884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine extended release: adjunctive treatment in major depressive disorder.
    Sanford M
    CNS Drugs; 2011 Sep; 25(9):803-13. PubMed ID: 21870891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial.
    Li H; Gu N; Zhang H; Wang G; Tan Q; Yang F; Ning Y; Zhang H; Lu Z; Xu X; Shi J; Gao C; Li L; Zhang K; Tian H; Wang X; Li K; Li H; Xu Y; Xie S; Yu X
    Psychopharmacology (Berl); 2016 Apr; 233(7):1289-97. PubMed ID: 26911380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.
    Chen YC; Chen CK; Wang LJ
    BMC Psychiatry; 2012 Sep; 12():162. PubMed ID: 23020711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder.
    Wang G; McIntyre A; Earley WR; Raines SR; Eriksson H
    Neuropsychiatr Dis Treat; 2014; 10():201-16. PubMed ID: 24511235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder.
    Wang G; McIntyre A; Earley WR; Raines S; Eriksson H
    Psychopharmacol Bull; 2012 Feb; 45(1):5-30. PubMed ID: 27738365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine Extended Release Open-Label Treatment Associated Changes in Amygdala Activation and Connectivity in Anxious Depression: An fMRI Study.
    Altinay M; Karne H; Beall E; Anand A
    J Clin Psychopharmacol; 2016 Dec; 36(6):562-571. PubMed ID: 27768670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
    Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
    Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial.
    Katzman MA; Brawman-Mintzer O; Reyes EB; Olausson B; Liu S; Eriksson H
    Int Clin Psychopharmacol; 2011 Jan; 26(1):11-24. PubMed ID: 20881846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
    Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
    J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
    Thase ME; Montgomery S; Papakostas GI; Bauer M; Trivedi MH; Svedsäter H; Locklear JC; Gustafsson U; Datto C; Eriksson H
    Int Clin Psychopharmacol; 2013 May; 28(3):113-20. PubMed ID: 23485955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.
    Rajagopalan K; Meyer K; O'Day K; Denno M; Loebel A
    J Med Econ; 2015; 18(10):821-7. PubMed ID: 25985265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.